Latest Investor Relations News

ALS Limited has announced an ordinary dividend of AUD 0.197 per share for the half-year ending March 2025, payable in July with flexible currency options for shareholders worldwide.

Otto Energy Limited has announced a special unfranked dividend of AUD 0.00143 per ordinary share, with key dates set for late May and mid-June 2025.

Trinex Minerals is set to seek shareholder approval for a significant 127:1 share consolidation aimed at streamlining its capital structure and enhancing investor appeal. The move also adjusts options and performance rights accordingly.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Adriatic Metals has confirmed ongoing discussions with Dundee Precious Metals regarding a possible takeover offer, marking the start of a formal offer period under the UK Takeover Code. While talks continue, no firm offer has yet been made.

Iltani Resources has raised $1.8 million through a share placement and launched a $1 million Share Purchase Plan to fund exploration at its promising Orient Silver-Indium Project.

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.

Top End Energy has appointed New York-based Amvest Capital to spearhead its U.S. investor engagement and plans an American Depositary Receipt listing by Q3 2025, aiming to open doors to one of the world’s largest energy capital markets.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.

Janus Electric Holdings Limited will have its trading suspension lifted and resume quotation on the ASX from 21 May 2025 after meeting key listing requirements.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

OFX Group Limited posted a 3.4% drop in revenue for FY25, with profits falling over 18%, while continuing its active share buy-back strategy.